Clinical Safety

Are First Responders Truly Ready for the Growing Fentanyl Crisis?
Biotech & Bioprocessing Are First Responders Truly Ready for the Growing Fentanyl Crisis?

The rising number of fentanyl-related overdose deaths and the dramatic increase in accidental exposures among children have highlighted the urgent need for enhanced biohazard training for first responders and property managers. Fentanyl's exceptional potency and widespread presence present

Is ICU Medical Facing Regulatory Challenges Over Infusion Pumps?
Management & Regulatory Is ICU Medical Facing Regulatory Challenges Over Infusion Pumps?

ICU Medical, a prominent medical device company based in California, is currently navigating significant regulatory challenges related to their infusion pumps. These challenges have emerged following an FDA warning, which highlighted the company's failure to adhere to essential regulatory

Nuclivision Raises €5M to Revolutionize PET Scans with AI
Tech & Innovation Nuclivision Raises €5M to Revolutionize PET Scans with AI

The medical industry constantly seeks advancements that improve patient care and diagnostic accuracy while reducing costs and risks. Belgian medtech startup Nuclivision has secured €5M in funding aimed at revolutionizing medical imaging through the integration of artificial intelligence and

Is Healthcare Ready for AI-Driven Personalized Medicine?
Tech & Innovation Is Healthcare Ready for AI-Driven Personalized Medicine?

Australia and New Zealand's healthcare systems are witnessing a transformative phase with the integration of Artificial Intelligence (AI). The merger of public health and personalized medicine spurred by AI technologies is raising critical concerns about preparedness at policy, regulatory, and

What Drives Growth in Global Medical Device Clinical Trials?
Management & Regulatory What Drives Growth in Global Medical Device Clinical Trials?

The global medical device clinical trials market is experiencing remarkable growth, with forecasts predicting an upward trajectory from USD 16.70 billion in 2024 to USD 30.53 billion by 2034. This substantial increase is largely driven by the pervasive rise in chronic diseases, which sets the stage

Disparities in Pancreatic Cancer Care Linked to Social Vulnerability
Tech & Innovation Disparities in Pancreatic Cancer Care Linked to Social Vulnerability

A recent study on metastatic pancreatic adenocarcinoma (mPDAC) patients reveals significant disparities in care based on race, socioeconomic status, and other social factors, impacting the outcomes and quality of care received. The study, co-authored by Dr. Diamantis Tsilimigras and Dr. Timothy M.

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later